BACKGROUND AND OBJECTIVES: There have been few studies investigating acute kidney injury (AKI) in patients infected with the 2009 pandemic influenza A (H1N1) virus. Therefore, the objective of this study was to identify the factors associated with AKI in H1N1-infected patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a study of 47 consecutive critically ill adult patients with reverse transcriptase-PCR-confirmed H1N1 infection in Brazil. Outcome measures were AKI (as defined by the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] criteria) and in-hospital death. RESULTS: AKI was identified in 25 (53%) of the 47 H1N1-infected patients. AKI was associated with vasopressor use, mechanical ventilation, high Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, and severe acidosis as well as with higher levels of C-reactive protein and lactic dehydrogenase upon intensive care unit (ICU) admission. A nephrology consultation was requested for 16 patients (64%), and 8 (50%) required dialysis. At ICU admission, 7 (15%) of the 25 AKI patients had not yet progressed to AKI. However, by 72 hours after ICU admission, no difference in RIFLE score was found between AKI survivors and nonsurvivors. Of the 47 patients, 9 (19%) died, all with AKI. Mortality was associated with mechanical ventilation, vasopressor use, dialysis, high APACHE II score, high bilirubin levels, and a low RIFLE score at ICU admission. CONCLUSIONS: Among critically ill H1N1-infected patients, the incidence of AKI is high. In such patients, AKI is mainly attributable to shock.
BACKGROUND AND OBJECTIVES: There have been few studies investigating acute kidney injury (AKI) in patients infected with the 2009 pandemic influenza A (H1N1) virus. Therefore, the objective of this study was to identify the factors associated with AKI in H1N1-infectedpatients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a study of 47 consecutive critically ill adult patients with reverse transcriptase-PCR-confirmed H1N1 infection in Brazil. Outcome measures were AKI (as defined by the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] criteria) and in-hospital death. RESULTS: AKI was identified in 25 (53%) of the 47 H1N1-infectedpatients. AKI was associated with vasopressor use, mechanical ventilation, high Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, and severe acidosis as well as with higher levels of C-reactive protein and lactic dehydrogenase upon intensive care unit (ICU) admission. A nephrology consultation was requested for 16 patients (64%), and 8 (50%) required dialysis. At ICU admission, 7 (15%) of the 25 AKI patients had not yet progressed to AKI. However, by 72 hours after ICU admission, no difference in RIFLE score was found between AKI survivors and nonsurvivors. Of the 47 patients, 9 (19%) died, all with AKI. Mortality was associated with mechanical ventilation, vasopressor use, dialysis, high APACHE II score, high bilirubin levels, and a low RIFLE score at ICU admission. CONCLUSIONS: Among critically ill H1N1-infectedpatients, the incidence of AKI is high. In such patients, AKI is mainly attributable to shock.
Authors: Rogelio Perez-Padilla; Daniela de la Rosa-Zamboni; Samuel Ponce de Leon; Mauricio Hernandez; Francisco Quiñones-Falconi; Edgar Bautista; Alejandra Ramirez-Venegas; Jorge Rojas-Serrano; Christopher E Ormsby; Ariel Corrales; Anjarath Higuera; Edgar Mondragon; Jose Angel Cordova-Villalobos Journal: N Engl J Med Date: 2009-06-29 Impact factor: 91.245
Authors: T Fislová; M Gocník; T Sládková; V Durmanová; J Rajcáni; E Varecková; V Mucha; F Kostolanský Journal: Arch Virol Date: 2009-02-03 Impact factor: 2.574
Authors: Thais Mauad; Ludhmila A Hajjar; Giovanna D Callegari; Luiz F F da Silva; Denise Schout; Filomena R B G Galas; Venancio A F Alves; Denise M A C Malheiros; Jose O C Auler; Aurea F Ferreira; Marcela R L Borsato; Stephania M Bezerra; Paulo S Gutierrez; Elia T E G Caldini; Carlos A Pasqualucci; Marisa Dolhnikoff; Paulo H N Saldiva Journal: Am J Respir Crit Care Med Date: 2009-10-29 Impact factor: 21.405
Authors: Rafael S A Lima; Cristina N Marques; Geraldo B Silva Júnior; Aline S Barbosa; Eveline S Barbosa; Rosa M S Mota; Sônia M H A Araújo; Oswaldo A Gutiérrez-Adrianzén; Alexandre B Libório; Elizabeth F Daher Journal: Int Urol Nephrol Date: 2008-03-27 Impact factor: 2.370
Authors: I W S Li; K H Chan; K W K To; S S Y Wong; P L Ho; S K P Lau; P C Y Woo; H W Tsoi; J F W Chan; V C C Cheng; B J Zheng; H Chen; K Y Yuen Journal: J Clin Virol Date: 2009-10-03 Impact factor: 3.168
Authors: Kelvin K W To; Kwok-Hung Chan; Iris W S Li; Tak-Yin Tsang; Herman Tse; Jasper F W Chan; Ivan F N Hung; Sik-To Lai; Chi-Wai Leung; Yat-Wah Kwan; Yu-Lung Lau; Tak-Keung Ng; Vincent C C Cheng; Joseph S M Peiris; Kwok-Yung Yuen Journal: J Med Virol Date: 2010-01 Impact factor: 2.327
Authors: Molly Fisher; Joel Neugarten; Eran Bellin; Milagros Yunes; Lindsay Stahl; Tanya S Johns; Matthew K Abramowitz; Rebecca Levy; Neelja Kumar; Michele H Mokrzycki; Maria Coco; Mary Dominguez; Kalyan Prudhvi; Ladan Golestaneh Journal: J Am Soc Nephrol Date: 2020-07-15 Impact factor: 10.121
Authors: Bhavna Bhasin; Vineet Veitla; Aprill Z Dawson; Zhuping Garacci; Daniel Sturgill; Mukoso N Ozieh; Kevin R Regner Journal: Kidney360 Date: 2021-02-26
Authors: Ignacio Martin-Loeches; Elisabeth Papiol; Alejandro Rodríguez; Emili Diaz; Rafael Zaragoza; Rosa María Granada; Lorenzo Socias; Juan Bonastre; Montserrat Valverdú; Juan Carlos Pozo; Pilar Luque; Jose Antonio Juliá-Narvaéz; Lourdes Cordero; Antonio Albaya; Daniel Serón; Jordi Rello Journal: Crit Care Date: 2011-02-22 Impact factor: 9.097